{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:55:13Z","timestamp":1781805313797,"version":"3.54.5"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/01.pra.0000428562.86705.cd","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T21:59:41Z","timestamp":1363989581000},"page":"157-161","source":"Crossref","is-referenced-by-count":33,"title":["Anti-NMDA Receptor Encephalitis"],"prefix":"10.1097","volume":"19","author":[{"given":"STEPHEN A.","family":"RYAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIEL J.","family":"COSTELLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EUGENE M.","family":"CASSIDY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GEMMA","family":"BROWN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUGH J.","family":"HARRINGTON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SANDER","family":"MARKX","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA- receptor encephalitis: Case series and analysis of the effects of antibodies.","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R2-9-20210210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal.","volume":"70","author":"Iizuka","year":"2008","journal-title":"Neurology"},{"key":"R3-9-20210210","first-page":"1047","article-title":"Anti-NMDA receptor encephalitis: Clinical manifestations and pathophysiology.","volume":"60","author":"Iizuka","year":"2008","journal-title":"Brain Nerve"},{"key":"R4-9-20210210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-Daspartate receptor (NMDAR) encephalitis in children and adolescents.","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"R5-9-20210210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/WCO.0b013e328347b307","article-title":"Movement disorders in paraneoplastic and autoimmune disease.","volume":"24","author":"Dalmau","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"Pt 6","key":"R6-9-20210210","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R7-9-20210210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N- methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R8-9-20210210","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.0b013e31822cfc6b","article-title":"Analysis of relapses in anti-NMDAR encephalitis.","volume":"77","author":"Gabilondo","year":"2011","journal-title":"Neurology"},{"key":"R9-9-20210210","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens Pathogenesis, associated disorders and antibody testing.","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"R10-9-20210210","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"R11-9-20210210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen.","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"R12-9-20210210","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: A novel glycine receptor antibody.","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"R13-9-20210210","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"R14-9-20210210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"R15-9-20210210","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.","volume":"54","author":"Gable","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R16-9-20210210","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: A unique EEG pattern in adults with anti-NMDA receptor encephalitis.","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"R18-9-20210210","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma.","volume":"118","author":"Tuzun","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R20-9-20210210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study.","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"R21-9-20210210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nn0110-2","article-title":"Testing the glutamate hypothesis of schizophrenia.","volume":"13","author":"Gordon","year":"2010","journal-title":"Nat Neurosci"},{"key":"R22-9-20210210","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archpsyc.59.7.663","article-title":"Effects of NMDA receptor antagonism: Implications for the pathophysiology of schizophrenia.","volume":"59","author":"Krystal","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R23-9-20210210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nn.2447","article-title":"Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.","volume":"13","author":"Belforte","year":"2010","journal-title":"Nat Neurosci"},{"key":"R24-9-20210210","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1192\/bjp.bp.111.092197","article-title":"Anti-NMDA receptor encephalitis: An important differential diagnosis in psychosis.","volume":"199","author":"Barry","year":"2011","journal-title":"Br J Psychiatry"},{"key":"R26-9-20210210","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/appi.ajp.2012.12050646","article-title":"Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.","volume":"169","author":"Masdeu","year":"2012","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Psychiatric Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.pra.0000428562.86705.cd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:30:23Z","timestamp":1620941423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131746-201303000-00009"}},"subtitle":["A Cause of Acute Psychosis and Catatonia"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pra.0000428562.86705.cd","relation":{},"ISSN":["1538-1145"],"issn-type":[{"value":"1538-1145","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}